Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BMY

Bristol-Myers Squibb Co.

Dec 01 • 04:00PM ET

50.10

Dollar change +0.72
Percentage change 1.46	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	S&P 500	P/E	12.71	EPS (ttm)	3.94	Insider Own	0.07%	Shs Outstand	2.10B	Perf Week	0.68%
Market Cap	101.94B	Forward P/E	6.82	EPS next Y	7.34	Insider Trans	-0.50%	Shs Float	2.03B	Perf Month	-2.30%
Income	8.29B	PEG	-	EPS next Q	1.76	Inst Own	78.76%	Short Float / Ratio	1.32% / 2.08	Perf Quarter	-19.22%
Sales	44.94B	P/S	2.27	EPS this Y	-2.05%	Inst Trans	-0.74%	Short Interest	26.80M	Perf Half Y	-23.70%
Book/sh	14.25	P/B	3.52	EPS next Y	-2.63%	ROA	8.75%	Target Price	64.05	Perf Year	-37.59%
Cash/sh	3.80	P/C	13.17	EPS next 5Y	-0.25%	ROE	26.87%	52W Range	48.25 - 81.43	Perf YTD	-30.37%
Dividend	2.25	P/FCF	8.72	EPS past 5Y	37.06%	ROI	13.22%	52W High	-38.48%	Beta	0.33
Dividend %	4.49%	Quick Ratio	1.07	Sales past 5Y	19.14%	Gross Margin	58.24%	52W Low	3.83%	ATR	1.08
Employees	34300	Current Ratio	1.18	Sales Q/Q	-2.25%	Oper. Margin	20.10%	RSI (14)	43.19	Volatility	1.84% 2.07%
Optionable	Yes	Debt/Eq	1.35	EPS Q/Q	24.93%	Profit Margin	18.44%	Rel Volume	0.99	Prev Close	49.38
Shortable	Yes	LT Debt/Eq	1.16	Earnings	Oct 26 BMO	Payout	74.28%	Avg Volume	12.90M	Price	50.10
Recom	2.48	SMA20	-0.69%	SMA50	-7.12%	SMA200	-19.83%	Volume	12,729,694	Change	1.46%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$68 → $55
Nov-09-23	Initiated	Deutsche Bank	Hold	$55
Nov-02-23	Downgrade	Daiwa Securities	Outperform → Neutral	$68 → $54
Oct-27-23	Upgrade	HSBC Securities	Reduce → Hold	$55 → $53
Oct-27-23	Downgrade	William Blair	Outperform → Mkt Perform
Oct-27-23	Downgrade	BMO Capital Markets	Outperform → Market Perform	$60
Oct-20-23	Resumed	UBS	Neutral	$70 → $60
Jul-14-23	Initiated	HSBC Securities	Reduce	$56
Jul-10-23	Initiated	SVB Securities	Market Perform	$66
Jun-28-23	Initiated	Daiwa Securities	Outperform	$70
Mar-06-23	Initiated	Jefferies	Hold	$62
Jan-17-23	Initiated	Cantor Fitzgerald	Overweight	$95
Nov-18-22	Initiated	Credit Suisse	Neutral	$78
Oct-10-22	Downgrade	Guggenheim	Buy → Neutral
Sep-14-22	Downgrade	Berenberg	Buy → Hold	$82 → $76
Jun-03-22	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-06-22	Resumed	Morgan Stanley	Underweight	$64
Dec-17-21	Initiated	Goldman	Buy	$72
Dec-09-21	Resumed	Wells Fargo	Equal Weight	$58
Nov-19-21	Initiated	BMO Capital Markets	Outperform	$72

Show Previous Ratings

Dec-01-23 01:56PM	Bristol Myers Squibb CEO Chris Boerner Buys Up Stock (Barrons.com)
07:05AM	Insider Buying: CEO Christopher Boerner Acquires Shares of Bristol-Myers Squibb Co (GuruFocus.com)
03:00AM	Bristol Myers Stock Is Slumping. One Director Bought Up Shares. (Barrons.com)
Nov-30-23 08:02AM	13 Best Stocks Under $50 To Buy Now (Insider Monkey)
Nov-28-23 02:51PM	FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells (The Wall Street Journal)
10:02AM	Loading…
10:02AM	Avidity Stock Soars on Collaboration Deal With Bristol Myers (Barrons.com)
07:01AM	Bristol Myers pours $100M into RNA drugs for cardiovascular diseases (BioPharma Dive)
06:30AM	Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC Platform Technology (PR Newswire)
Nov-26-23 06:51AM	15 Best Drug Stocks To Invest In (Insider Monkey)
Nov-24-23 05:30AM	Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale (Motley Fool)
Nov-23-23 04:47PM	Corrections & Amplifications (The Wall Street Journal)
Nov-22-23 04:01PM	12 High Dividend Stocks Picked By Billionaire Ray Dalio (Insider Monkey)
09:09AM	Dividend Achievers List Ranked By Yield: Top 30 (Insider Monkey)
05:04AM	Director Samuels Theodore R. II Bolsters Confidence in Bristol-Myers Squibb Co with Recent ... (GuruFocus.com)
Nov-21-23 10:15AM	Bristol Myers (BMY), TSVT Cell Therapy Abecma Faces Setback (Zacks)
04:55PM	Loading…
Nov-20-23 04:55PM	US STOCKS-Nasdaq leads Wall Street gains as Microsoft hits record (Reuters)
04:48PM	Bayer stock plunges after drug trial halted (Yahoo Finance Video)
03:16PM	Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case (The Wall Street Journal)
02:56PM	US STOCKS-Nasdaq leads Wall Street's gains as Microsoft hits record high (Reuters)
01:25PM	Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug (TheStreet.com)
12:32PM	Midday Movers: Boeing and GM Advance, Bristol-Myers Squibb Declines (Investopedia)
12:17PM	Stock Market Builds Gains; Nvidia Stock Lifts As Earnings Loom (Investor's Business Daily)
12:02PM	Bristol-Myers Squibb, 2seventy Bio Shares Fall as FDA Delays Decision on Cancer Drug (Investopedia)
11:58AM	Bayer Stock Plunges, Bristol Myers Squibb Falls After Negative Drug-Trial Result (The Wall Street Journal)
11:58AM	Bayer Stock Plunges After Negative Drug-Trial Result; Bristol Myers Squibb Also Falls (The Wall Street Journal)
11:47AM	Why Bristol Myers Squibb Stock Is Fading Today (Motley Fool)
11:03AM	Stock Market Pulls Ahead To Start The Holiday Week; Boeing Leads The Dow (Investor's Business Daily)
10:38AM	Stocks to Watch Monday: Microsoft, Bayer, Zoom (The Wall Street Journal)
10:08AM	Why Is Bristol-Myers Squibb (BMY) Stock Down Today? (InvestorPlace)
09:42AM	Bristol Myers Squibb Stock Falls After Drug Approval Delayed (Barrons.com)
08:51AM	Loading…
08:51AM	Billionaire Jim Simons Top 12 High-Dividend Stocks (Insider Monkey)
08:30AM	UPDATE 1-US FDA may delay decision on Bristol Myers-2seventy bio cancer therapy (Reuters)
07:18AM	US FDA delays decision on Bristol Myers-2seventy bio cancer therapy (Reuters)
06:59AM	Bristol Myers Squibb and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma (Business Wire)
06:52AM	20 Most Valuable Healthcare Companies in the World (Insider Monkey)
Nov-19-23 08:15AM	13 Best Dividend Stocks with Upside Potential (Insider Monkey)
Nov-17-23 10:45AM	How Is BMS Making Progress on Its Renewable Energy Goals? (ACCESSWIRE)
Nov-16-23 11:17AM	Bristol Myers (BMY) Receives FDA Approval for NSCLC Drug (Zacks)
07:08AM	FDA approves new Bristol Myers drug for lung cancer (BioPharma Dive)
05:59AM	Could Bristol-Myers Squibb Stock Help You Retire A Millionaire? (Motley Fool)
Nov-15-23 07:20PM	U.S. Food and Drug Administration Approves Augtyro (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) (Business Wire)
05:06PM	UPDATE 3-US FDA approves Bristol-Myers' lung cancer drug (Reuters)
05:01PM	US FDA approves Bristol-Myers' lung cancer drug (Reuters)
03:04AM	Bristol-Myers Squibb slashed, Energizer hit with 3 downgrades: 4 big analyst cuts (Investing.com)
Nov-14-23 10:01AM	Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment (Motley Fool)
08:45AM	Global Oncology Drugs Market Size Projected to Reach $484 Billion by 2030 (PR Newswire)
07:14AM	12 Best Buy-the-Dip Stocks To Buy Now (Insider Monkey)
Nov-13-23 02:00PM	Developing new medicines for everyone, everywhere, equally (Fortune)
06:30AM	Anthos blood thinner bests Xarelto on safety in mid-stage study (BioPharma Dive)
Nov-11-23 07:25AM	Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win? (Motley Fool)
Nov-09-23 04:18PM	Bristol Myers Squibb to Participate in the 2023 Jefferies London Healthcare Conference (Business Wire)
10:14AM	U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibbs Application for Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) (Business Wire)
08:45AM	Global Anal Cancer Market Size Expected to Reach $1.24 Billion In 2028 as Treatments Advance (PR Newswire)
03:47AM	Top 5 Drug Companies in the US by Revenue (Insider Monkey)
Nov-08-23 09:50AM	Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role (GlobeNewswire)
05:21AM	3 No-Brainer Stocks to Buy With $500 Right Now (Motley Fool)
Nov-06-23 09:02AM	Mirati Therapeutics Inc (MRTX) Reports Q3 2023 Financial Results (GuruFocus.com)
07:54AM	Bristol Myers buys Orum's blood cancer therapy for up to $180 million (Reuters)
07:41AM	UPDATE 1-Bristol Myers buys Orum's blood cancer therapy for up to $180 mln (Reuters)
07:12AM	Bristol Myers Squibb buys Orum's blood cancer therapy for up to $180 mln (Reuters)
06:59AM	Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023 (Business Wire)
02:00AM	Bristol Myers pays $100M for a different kind of ADC (BioPharma Dive)
Nov-02-23 07:03PM	Prothena Corp PLC (PRTA) Reports Q3 2023 Financial Results (GuruFocus.com)
11:34AM	Bristol Myers Squibbs First Disclosures and New Data at ASH 2023 Highlight Companys Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology (Business Wire)
06:59AM	Bristol Myers Squibb to Participate in the 2023 UBS BioPharma Conference (Business Wire)
Oct-31-23 06:25PM	Bristol Myers Squibb Appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, Effective April 1, 2024 (Business Wire)
03:49AM	10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts (Insider Monkey)
Oct-30-23 08:19PM	Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes (Business Wire)
04:35PM	13 Most Undervalued Pharma Stocks To Buy According To Analysts (Insider Monkey)
03:42PM	High-Grade Companies Raise $22.5 Billion in Bond Flurry (Bloomberg)
11:08AM	Drug Stocks Keep Tanking on Earnings. It Could Be a Long Week. (Barrons.com)
09:50AM	20 Foods That Lower Cholesterol Fast (Insider Monkey)
08:00AM	Karyopharm Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Novel CELMoD Agent CC- 92480 Mezigdomide in Combination with Selinexor in Patients with Relapsed/Refractory Multiple Myeloma (PR Newswire)
06:59AM	European Medicines Agency Validates Bristol Myers Squibbs Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma (Business Wire)
06:18AM	5 Best Stocks to Buy for Income (Insider Monkey)
05:46AM	11 Best Pharma Stocks To Buy Now (Insider Monkey)
05:24AM	5 Best Immunotherapy Stocks To Buy Now (Insider Monkey)
Oct-28-23 03:23PM	Bristol-Myers Squibb Company (NYSE:BMY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-27-23 10:01AM	Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls (The Fly)
08:32AM	Why LianBio Stock Is Shooting Through the Roof This Week (Motley Fool)
07:15AM	The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical (Zacks)
Oct-26-23 11:43PM	Q3 2023 Bristol-Myers Squibb Co Earnings Call (Thomson Reuters StreetEvents) -6.43%
05:58PM	Analyst Report: Bristol-Myers Squibb Company (Morningstar Research)
04:50PM	Bristol Myers Squibb Revenue Falls on Generic Competition for Key Drug (Investopedia)
04:03PM	Bristol Myers Skids After Pushing Back A Key $10 Billion Sales Milestone (Investor's Business Daily)
03:30PM	Bristol Myers Squibb Shares Headed for Worst Day in Over a Year (Barrons.com)
02:00PM	Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript (Motley Fool)
12:13PM	Bristol-Myers Squibb: Not a Good Prescription for Investors Right Now (TheStreet.com)
12:13PM	Bristol-Myers (BMY) Q3 Earnings & Sales Beat, Opdivo Sales Grow (Zacks)
12:09PM	Bristol-Myers Squibb Delays Windfall From New Drugs by a Year (The Wall Street Journal)
11:28AM	Biotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News (Zacks)
10:54AM	Advance GDP Estimate Comes in Higher Than Expectations (Zacks)
10:25AM	Q3 GDP +4.9%, Earnings Beats for UPS, Bristol Myers and Honeywell (Zacks)
09:50AM	Bristol-Myers Delays Windfall From New Drugs by a Year (The Wall Street Journal)
09:30AM	Compared to Estimates, Bristol Myers (BMY) Q3 Earnings: A Look at Key Metrics (Zacks)
09:22AM	Bristol-Myers Squibb Co (BMY) Reports Q3 2023 Earnings (GuruFocus.com)
09:04AM	Bristol Myers Skids 5% After Pushing Back A Key Sales Milestone By A Year (Investor's Business Daily)
08:15AM	Bristol Myers Squibb (BMY) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:45AM	Bristol Myers Revenue Declines but Beats Expectations as Revlimid Sales Drop (Barrons.com)
07:43AM	Bristol-Myers Squibb Boosts FY23 Adj. EPS Outlook As Q3 Adj. EPS Tops Estimates (RTT News)

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOERNER CHRISTOPHER S.	Chief Executive Officer	Nov 28	Buy	48.86	3,071	150,049	79,384	Nov 30 06:32 PM
Samuels Theodore R. II	Director	Nov 20	Buy	49.81	8,500	423,385	35,500	Nov 21 07:01 PM
Powell Ann	EVP, Chief Human Resources	Aug 24	Sale	61.25	17,986	1,101,642	27,868	Aug 28 05:28 PM
Plenge Robert M	EVP, Chief Research Officer	Aug 03	Sale	61.14	732	44,754	6,584	Aug 07 05:24 PM
Weese Michelle	EVP, Corporate Affairs	Jul 01	Option Exercise	0.00	1,885	0	4,135	Jul 05 05:26 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Jul 01	Option Exercise	0.00	9,357	0	52,032	Jul 05 05:23 PM
Lenkowsky Adam	EVP, Chief Commercial Officer	Jun 03	Option Exercise	0.00	1,077	0	1,077	Jun 06 07:39 PM
VESSEY RUPERT	EVP & President, Research	May 03	Sale	67.06	50,385	3,378,818	47,751	May 04 05:51 PM
Greenlees Sharon	SVP & Controller	May 02	Option Exercise	0.00	1,017	0	728	May 03 07:36 PM
Mily Elizabeth	EVP, Strategy & BD	Apr 01	Option Exercise	0.00	6,346	0	35,873	Apr 04 08:40 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Apr 01	Option Exercise	0.00	3,306	0	4,918	Apr 04 08:40 PM
Mily Elizabeth	EVP, Strategy & BD	Mar 10	Option Exercise	0.00	29,636	0	38,173	Mar 14 08:40 PM
VESSEY RUPERT	EVP & President, Research	Mar 10	Option Exercise	0.00	66,935	0	118,263	Mar 14 08:34 PM
LEUNG SANDRA	EVP, General Counsel	Mar 10	Option Exercise	0.00	57,990	0	356,920	Mar 14 08:28 PM
Powell Ann	EVP, Chief Human Resources	Mar 10	Option Exercise	0.00	34,447	0	53,100	Mar 14 08:18 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Mar 10	Option Exercise	0.00	38,978	0	54,035	Mar 14 08:18 PM
Weese Michelle	EVP, Corporate Affairs	Mar 10	Option Exercise	0.00	1,590	0	2,793	Mar 14 08:14 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Mar 10	Option Exercise	0.00	2,447	0	2,447	Mar 14 08:12 PM
Caforio Giovanni	Board Chair and CEO	Mar 10	Option Exercise	0.00	234,676	0	431,381	Mar 14 08:13 PM
Elkins David V	EVP, Chief Financial Officer	Mar 10	Option Exercise	0.00	71,871	0	185,308	Mar 14 08:13 PM
BOERNER CHRISTOPHER S.	EVP, Chief Commercial Officer	Mar 10	Option Exercise	0.00	59,111	0	91,880	Mar 14 08:13 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Mar 10	Option Exercise	0.00	2,836	0	4,648	Mar 14 08:14 PM
Caforio Giovanni	Board Chair and CEO	Feb 06	Sale	74.65	240,000	17,916,000	236,104	Feb 08 08:09 PM
Powell Ann	EVP, Chief Human Resources	Feb 06	Sale	74.69	11,183	835,258	23,043	Feb 08 08:09 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Feb 01	Option Exercise	0.00	2,543	0	2,543	Feb 03 07:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BMY

Bristol-Myers Squibb Co.

Upgrade your FINVIZ experience